Satu Kuure

Dr. Satu Kuure

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2008 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
HNHeidi O Nousiainen
Heidi O Nousiainen
MKMarjo Kestilä
Marjo Kestilä
NPNiklas Pakkasjärvi
Niklas Pakkasjärvi
HHHeli Honkala
Heli Honkala
SKSatu Kuure
Satu Kuure
LPLeena Peltonen
Leena Peltonen

1 May 2008 in Developmental Biology
Verified
Journal Article
Closed access
DBDarren Bridgewater
Darren Bridgewater
BCBrian Cox
Brian Cox
JCJason Cain
Jason Cain
ALAgnes Lau
Agnes Lau
VAValerie Athaide
Valerie Athaide
NRNorman D. Rosenblum
Norman D. Rosenblum

1 April 2007 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
SKSatu Kuure
Satu Kuure
APAnna Popsueva
Anna Popsueva
MJMadis Jakobson
Madis Jakobson
KSKirsi Sainio
Kirsi Sainio
HSHannu Sariola
Hannu Sariola
Wnt proteins are required for induction of nephrons in mouse metanephric kidneys, but the downstream pathways that mediate tubule induction and epithelial differentiation have remained obscure. The intracellular mechanisms by which Wnt signaling mediates nephron induction in embryonic kidney mesenchymes were studied. First is shown that transient exposure of isolated kidney mesenchymes to structurally different glycogen synthase kinase-3 (GSK3) inhibitors lithium or 6-bromoindirubin-3′-oxime results in abundant epithelial differentiation and full segregation of nephrons. Shown further by mice with genetically disrupted ureteric bud or Wolffian duct development is that this nephrogenic competence arises independent of the influence of Wolffian duct–derived epithelia. Analysis of the intracellular signaling cascades downstream of GSK3 inhibition revealed stabilization of β-catenin and upregulation of Lef1 and Tcf1, both events that are associated with the active canonical Wnt signaling. Last, genetic evidence that metanephric mesenchyme–specific stabilization of β-catenin is sufficient to induce nephron differentiation in isolated kidney mesenchymes, similar to that induced by GSK3 inhibitors, is provided. These data show that activation of canonical Wnt pathway is sufficient to induce nephrogenesis and suggest that this pathway mediates the nephron induction in murine kidney mesenchymes.

17 December 2015 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
AKAnmol Kumar
Anmol Kumar
JKJaakko Juha Kopra
Jaakko Juha Kopra
KVKärt Varendi
Kärt Varendi
LPLauriina L. Porokuokka
Lauriina L. Porokuokka
APAnne Panhelainen
Anne Panhelainen
Jaan-Olle AndressooJaan-Olle Andressoo
Jaan-Olle Andressoo
Degeneration of nigrostriatal dopaminergic system is the principal lesion in Parkinson’s disease. Because glial cell line-derived neurotrophic factor (GDNF) promotes survival of dopamine neurons in vitro and in vivo, intracranial delivery of GDNF has been attempted for Parkinson’s disease treatment but with variable success. For improving GDNF-based therapies, knowledge on physiological role of endogenous GDNF at the sites of its expression is important. However, due to limitations of existing genetic model systems, such knowledge is scarce. Here, we report that prevention of transcription of Gdnf 3’UTR in Gdnf endogenous locus yields GDNF hypermorphic mice with increased, but spatially unchanged GDNF expression, enabling analysis of postnatal GDNF function. We found that increased level of GDNF in the central nervous system increases the number of adult dopamine neurons in the substantia nigra pars compacta and the number of dopaminergic terminals in the dorsal striatum. At the functional level, GDNF levels increased striatal tissue dopamine levels and augmented striatal dopamine release and re-uptake. In a proteasome inhibitor lactacystin-induced model of Parkinson’s disease GDNF hypermorphic mice were protected from the reduction in striatal dopamine and failure of dopaminergic system function. Importantly, adverse phenotypic effects associated with spatially unregulated GDNF applications were not observed. Enhanced GDNF levels up-regulated striatal dopamine transporter activity by at least five fold resulting in enhanced susceptibility to 6-OHDA, a toxin transported into dopamine neurons by DAT. Further, we report how GDNF levels regulate kidney development and identify microRNAs miR-9, miR-96, miR-133, and miR-146a as negative regulators of GDNF expression via interaction with Gdnf 3’UTR in vitro. Our results reveal the role of GDNF in nigrostriatal dopamine system postnatal development and adult function, and highlight the importance of correct spatial expression of GDNF. Furthermore, our results suggest that 3’UTR targeting may constitute a useful tool in analyzing gene function. Intracranial delivery of GDNF has been attempted for Parkinson’s disease (PD) treatment but with variable success. For improving GDNF-based therapies, knowledge on physiological role of endogenous GDNF at the sites of its expression is important. However, due to limitations of existing genetic model systems, such knowledge is scarce. Here, we utilize an innovative genetic approach by targeting the 3’UTR regulation of Gdnf in mice. Such animals express elevated levels of Gdnf exclusively in natively Gdnf-expressing cells, enabling dissection of endogenous GDNF functions in vivo. We show that endogenous GDNF regulates dopamine system development and function and protects mice in a rodent PD model without side effects associated with ectopic GDNF applications. Further, we report how GDNF levels regulate kidney development and identify microRNAs which control GDNF expression. Our study highlights the importance of correct spatial expression of GDNF and opens a novel approach to study gene function in mice.

Verified
Journal Article
Open access
PDF file
KKKristen Kurtzeborn
Kristen Kurtzeborn
HKHYUK NAM KWON
HYUK NAM KWON
SKSatu Kuure
Satu Kuure
Congenital anomalies of the kidney and urinary tract (CAKUT) are common birth defects derived from abnormalities in renal differentiation during embryogenesis. CAKUT is the major cause of end-stage renal disease and chronic kidney diseases in children, but its genetic causes remain largely unresolved. Here we discuss advances in the understanding of how mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) activity contributes to the regulation of ureteric bud branching morphogenesis, which dictates the final size, shape, and nephron number of the kidney. Recent studies also demonstrate that the MAPK/ERK pathway is directly involved in nephrogenesis, regulating both the maintenance and differentiation of the nephrogenic mesenchyme. Interestingly, aberrant MAPK/ERK signaling is linked to many cancers, and recent studies suggest it also plays a role in the most common pediatric renal cancer, Wilms’ tumor.

1 September 2015 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
TATadayuki Akagi
Tadayuki Akagi
SKSatu Kuure
Satu Kuure
KUKousuke Uranishi
Kousuke Uranishi
HKHiroshi Koide
Hiroshi Koide
FCFrank Costantini
Frank Costantini
TYTakashi Yokota
Takashi Yokota
The pluripotency and self-renewal capacity of embryonic stem (ES) cells is regulated by several transcription factors. Here, we show that the ETS-related transcription factors ETV4 and ETV5 (ETV4/5) are specifically expressed in undifferentiated ES cells, and suppression of Oct3/4 results in down-regulation of ETV4/5. Simultaneous deletion of ETV4 and ETV5 (ETV4/5 double knockout, dKO) in ES cells resulted in flat, epithelial cell like appearance, while the morphology changed into compact colonies in a 2i medium (containing two inhibitors for GSK3 and MEK/ERK). Expression levels of self-renewal marker genes, including Oct3/4 and Nanog, were similar between wild-type and dKO ES cells, whereas proliferation of ETV4/5 dKO ES cells was decreased with overexpression of cyclin-dependent inhibitors (p16/p19, p15, and p57). A differentiation assay revealed that the embryoid bodies derived from ETV4/5 dKO ES cells were smaller than the control, and expression of ectoderm marker genes, including Fgf5, Sox1, and Pax3, was not induced in dKO derived embryiod bodies. Microarray analysis demonstrated that stem cell-related genes, including Tcf15, Gbx2, LRH1, Zic3, and Baf60c, were significantly repressed in ETV4/5 dKO ES cells. The artificial expression of ETV4 and/or ETV5 in ETV4/5 dKO ES cells induced re-expression of Tcf15 and Gbx2. These results indicate that ETV4 and ETV5, potentially through regulation of Gbx2 and Tcf15, are involved in the ES cell proliferation, and induction of differentiation-associated genes in ES cells.